IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 24.320
NA - Nord America 11.789
EU - Europa 4.698
SA - Sud America 1.928
AF - Africa 235
Continente sconosciuto - Info sul continente non disponibili 137
OC - Oceania 74
AN - Antartide 3
Totale 43.184
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 15.458
US - Stati Uniti d'America 11.229
CN - Cina 3.727
HK - Hong Kong 3.016
IT - Italia 2.198
BR - Brasile 1.415
GB - Regno Unito 808
VN - Vietnam 788
FR - Francia 653
IN - India 309
DE - Germania 291
BD - Bangladesh 290
CA - Canada 278
AR - Argentina 219
MX - Messico 166
ID - Indonesia 124
NL - Olanda 111
ZA - Sudafrica 97
TR - Turchia 84
JP - Giappone 80
FI - Finlandia 75
EC - Ecuador 74
UA - Ucraina 73
AU - Australia 67
PL - Polonia 64
RU - Federazione Russa 60
CO - Colombia 59
ES - Italia 55
SA - Arabia Saudita 54
IQ - Iraq 51
PY - Paraguay 50
CL - Cile 38
PK - Pakistan 38
SE - Svezia 37
CZ - Repubblica Ceca 35
UZ - Uzbekistan 32
MD - Moldavia 31
PH - Filippine 31
PE - Perù 30
MY - Malesia 27
MA - Marocco 25
VE - Venezuela 23
JM - Giamaica 22
EG - Egitto 21
BE - Belgio 19
CH - Svizzera 19
CR - Costa Rica 19
EE - Estonia 18
LT - Lituania 18
NP - Nepal 18
KR - Corea 17
AZ - Azerbaigian 16
UY - Uruguay 15
DZ - Algeria 14
ET - Etiopia 13
AE - Emirati Arabi Uniti 12
DO - Repubblica Dominicana 12
KZ - Kazakistan 12
TH - Thailandia 12
AT - Austria 11
HN - Honduras 11
IL - Israele 11
RO - Romania 11
TN - Tunisia 11
BH - Bahrain 10
GT - Guatemala 10
KE - Kenya 10
SI - Slovenia 10
TW - Taiwan 10
GR - Grecia 9
OM - Oman 9
PT - Portogallo 9
RS - Serbia 9
AL - Albania 8
BA - Bosnia-Erzegovina 8
HU - Ungheria 8
IE - Irlanda 8
JO - Giordania 8
KG - Kirghizistan 8
PS - Palestinian Territory 8
KH - Cambogia 7
NI - Nicaragua 7
SK - Slovacchia (Repubblica Slovacca) 7
SV - El Salvador 7
SY - Repubblica araba siriana 7
BG - Bulgaria 6
BY - Bielorussia 6
CY - Cipro 6
KW - Kuwait 6
TT - Trinidad e Tobago 6
DK - Danimarca 5
LB - Libano 5
PA - Panama 5
AM - Armenia 4
BO - Bolivia 4
DM - Dominica 4
GA - Gabon 4
IR - Iran 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
Totale 42.952
Salva come PNG Salva come JPEG
Città #
San Jose 3.883
Hong Kong 2.994
Ashburn 2.702
Singapore 2.356
Rome 1.639
Hefei 1.390
Boardman 802
Beijing 734
London 674
Lauterbourg 593
Shanghai 489
Dallas 468
Santa Clara 324
Ho Chi Minh City 263
Los Angeles 192
New York 179
Hanoi 177
San Francisco 167
Council Bluffs 151
São Paulo 137
Seattle 107
Pune 106
Toronto 106
Munich 95
Mexico City 94
Washington 69
Tokyo 61
Warsaw 55
Rio de Janeiro 52
Amsterdam 51
Orem 49
Brooklyn 47
Chicago 43
Johannesburg 43
Montreal 43
Chennai 40
Frankfurt am Main 40
Milan 40
Turku 40
Helsinki 35
Haiphong 34
Melbourne 33
Da Nang 32
Phoenix 30
Tashkent 30
Boston 29
Brno 29
Naples 29
Belo Horizonte 28
Thái Bình 28
Biên Hòa 27
Las Vegas 27
Stockholm 27
Atlanta 26
Quito 25
Riyadh 25
Buenos Aires 23
Hangzhou 23
Asunción 22
Baghdad 21
Guayaquil 21
Manchester 21
New Delhi 21
Jeddah 20
Ribeirão Preto 20
Secaucus 20
Bogotá 19
Brasília 19
Curitiba 19
Lima 19
St Louis 19
Charlotte 18
Buffalo 17
Campinas 17
Kingston 17
San José 17
Canberra 16
Jakarta 16
Ninh Bình 16
Sydney 16
West Jordan 16
Ankara 15
Porto Alegre 15
Guangzhou 14
Istanbul 14
Addis Ababa 13
Bologna 13
Denver 13
Hyderabad 13
Manaus 13
Mumbai 13
Palermo 13
Paris 13
Philadelphia 13
Salvador 13
Baku 12
Caxias do Sul 12
Goiânia 12
Hanover 12
Hasselt 12
Totale 22.710
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 273
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 258
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 257
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 249
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 248
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 241
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 240
Early impairment of food intake in patients newly diagnosed with cancer 235
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 235
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 235
Designing a broad-spectrum integrative approach for cancer prevention and treatment 235
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 233
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 233
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 232
A key opinion leader interview with Prof D Santini: insight into cancer research. 231
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 229
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 227
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 224
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 223
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 223
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 219
Premetastatic niche: ready for new therapeutic interventions? 218
Prevention of radiotherapy-induced emesis 218
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 218
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 217
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 216
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 215
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 215
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 215
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 214
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 213
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 211
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 208
Docetaxel induced pericardial effusion 206
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 203
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 202
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 200
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 196
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 191
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 178
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 168
A giant sarcoma of the parotid gland: A case report and review of the literature 163
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 155
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 153
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 146
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 146
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 146
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 143
'Old' and 'new' drugs for the treatment of cancer pain 141
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 139
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 137
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 137
Anestesia e malattie non comuni 137
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 137
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 136
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 133
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 133
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 132
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 132
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 131
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 129
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 128
Colorectal carcinomas and PTEN/MMAC1 gene mutations 128
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 127
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 127
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 127
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 126
Biological effects of cabozantinib on bone microenvironment 126
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 124
[Treatment of stage-I seminoma. Critical review] 124
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 124
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 123
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 123
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 123
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 121
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 118
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 117
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 117
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 117
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 116
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 116
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 114
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 114
Atypical chronic head and neck pain: don't forget Eagle's syndrome 113
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 112
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 112
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 111
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 111
Idiosyncratic reaction after oxaliplatin infusion 110
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 109
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 106
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 106
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 106
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 102
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 101
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 99
Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study 98
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 96
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 93
A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients 93
Totale 16.366
Salva come PNG Salva come JPEG
Categoria #
all - tutte 348.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 348.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 4 5 8 73 10 15 4 42 20 23 804
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.295 52 281 95 171 237 1.039 17 154 23 59 75 92
2024/202518.553 334 274 922 147 171 510 314 63 1.954 1.573 5.751 6.540
2025/202620.637 1.870 776 1.374 2.466 701 1.230 5.302 1.801 1.703 1.872 816 726
2026/2027488 396 92 0 0 0 0 0 0 0 0 0 0
Totale 43.184